Skip to main content
Clinical Trials/CTRI/2024/06/068756
CTRI/2024/06/068756CompletedPhase 3

Efficacy of Homoeopathic Intervention Glonoine 30 in Preventing Heat Related illness: A Cluster-randomized, Double Blind, Parallel Arm, Placebo-Controlled Trial

Central Council for Research in Homoeopathy, New Delhi, Ministry of AYUSH, Government of India1 site in 1 country25,000 target enrollmentStarted: June 22, 2024Last updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
25,000
Locations
1
Primary Endpoint
Incidence of headache, tiredness, extreme fatigue/lethargy, skin rash/ bumps, Painful muscle cramps/ spasm, Nausea, vomiting, loose motion, constipation, stomach cramps, chills, dizziness, fainting, confusion, extreme thirst, heat sensation on head or neck, heavy sweating, muscle weakness induced due to exposure of heatwave

Study Overview

Brief Summary

This is a prospective, randomized, double blind, placebo controlled trial to assess the effectiveness of homoeopathic medicine Glonoine 30 for prevention of Heat related illness. The study is a field study wherein apparently healthy participants will be enrolled from the population residing in 05 urban slums of Delhi, where there is significant chance of getting affected by heat related illness. Study participants who fulfil    the inclusion criteria and willing to provide informed written consent shall be enrolled in the study and randomized to either group as below:

Group I - H+GM’ Arm - Homoeopathic intervention Glonoine 30 along with IEC regarding general measures for prevention of heat related illnesses will be provided to 03 clusters.

Group II - â€˜P+GM’ Arm - Placebo along with IEC regarding general measures for prevention of heat related illnesses will be provided to 02 clusters.

The study will be carried out till the termination of heat wave as per Indian Meteorological Department. The primary outcome shall be incidence of heat related illness amongst population of 05 slums.

Study Design

Study Type
Interventional
Allocation
Randomized
Masking
Participant and Investigator Blinded

Eligibility Criteria

Ages
1.00 Year(s) to 99.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Voluntary written Informed consent by the family head.

Exclusion Criteria

  • Pregnant or lactating females.
  • Child below age of 1 year.
  • Patients with malignancy, immune-compromised state, life threatening diseases, end stage diseases Patient with symptoms of acute infectious illnesses at the time of enrolment.

Outcomes

Primary Outcomes

Incidence of headache, tiredness, extreme fatigue/lethargy, skin rash/ bumps, Painful muscle cramps/ spasm, Nausea, vomiting, loose motion, constipation, stomach cramps, chills, dizziness, fainting, confusion, extreme thirst, heat sensation on head or neck, heavy sweating, muscle weakness induced due to exposure of heatwave

Time Frame: Daily

Secondary Outcomes

  • Intensity of symptoms (headache, tiredness, extreme fatigue/lethargy, skin rash/ bumps, Painful muscle cramps/ spasm, Nausea, vomiting, loose motion, constipation, stomach cramps, chills, dizziness, fainting, confusion, extreme thirst, heat sensation on head or neck, heavy sweating, muscle weakness) induced due to exposure of heatwave(Daily)
  • Mean duration of symptoms (headache, tiredness, extreme fatigue/lethargy, skin rash/ bumps, Painful muscle cramps/ spasm, Nausea, vomiting, loose motion, constipation, stomach cramps, chills, dizziness, fainting, confusion, extreme thirst, heat sensation on head or neck, heavy sweating, muscle weakness) induced due to exposure of heatwave(Daily)
  • Proportion of cases of heat related illnesses requiring hospitalization(At the time of analysis)

Investigators

Sponsor
Central Council for Research in Homoeopathy, New Delhi, Ministry of AYUSH, Government of India
Sponsor Class
Government funding agency
Responsible Party
Principal Investigator
Principal Investigator

Dr Debadatta Nayak

Central Council for Research in Homoeopathy

Study Sites (1)

Loading locations...

Similar Trials